Cathelicidin LL-37: A defense molecule with a potential role in psoriasis pathogenesis

Experimental Dermatology

Volumn 21, Issue 5, 2012, Pages 327-330

  Dombrowski, Yvonne ^a   Schauber, Jürgen ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

AIM2; Cathelicidin; Cytosolic DNA; Inflammasome; LL 37; Psoriasis

Indexed keywords

ALPHA INTERFERON; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CUTANEOUS LYMPHOCYTE ASSOCIATED ANTIGEN; INFLAMMASOME; INTERLEUKIN 1BETA; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; VITAMIN D DERIVATIVE;

HUMAN; INNATE IMMUNITY; MOLECULAR PATHOLOGY; MYELOID DENDRITIC CELL; NOTE; PLASMACYTOID DENDRITIC CELL; PSORIASIS; PSORIASIS VULGARIS; TOPICAL TREATMENT; ULTRAVIOLET B RADIATION;

ANTIMICROBIAL CATIONIC PEPTIDES; DNA; HUMANS; IMMUNITY, INNATE; INFLAMMASOMES; KERATINOCYTES; PSORIASIS; SIGNAL TRANSDUCTION; VITAMIN D;

EID: 84859896106     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2012.01459.x     Document Type: Note

References (70)

1. Bardan A, Nizet V, Gallo R L. Expert Opin Biol Ther 2004: 4: 543-549.
2. Schauber J, Gallo R L. J Allergy Clin Immunol 2008: 122: 261-266.
3. Braff M H, Bardan A, Nizet V et al. J Invest Dermatol 2005: 125: 9-13.
4. Di Nardo A, Vitiello A, Gallo R L. J Immunol 2003: 170: 2274-2278.
5. Gudmundsson G H, Agerberth B. J Immunol Methods 1999: 232: 45-54.
6. Agerberth B, Charo J, Werr J et al. Blood 2000: 96: 3086-3093.
7. Harder J, Schroder J M. J Biol Chem 2002: 277: 46779-46784.
8. Harder J, Bartels J, Christophers E et al. Nature 1997: 387: 861.
9. Glaser R, Harder J, Lange H et al. Nat Immunol 2005: 6: 57-64.
10. Peric M, Koglin S, Kim S M et al. J Immunol 2008: 181: 8504-8512.
11. Harder J, Bartels J, Christophers E et al. J Biol Chem 2001: 276: 5707-5713.
12. Schauber J, Dorschner R A, Coda A B et al. J Clin Invest 2007: 117: 803-811.
13. Wolk K, Witte E, Wallace E et al. Eur J Immunol 2006: 36: 1309-1323.
14. Yamasaki K, Schauber J, Coda A et al. FASEB J 2006: 20: 2068-2080.
15. Michaelson D, Rayner J, Couto M et al. J Leukoc Biol 1992: 51: 634-639.
16. Schauber J, Gallo R L. J Invest Dermatol 2007: 127: 510-512.
17. Lai Y, Gallo R L. Trends Immunol 2009: 30: 131-141.
18. Oppenheim J J, Tewary P, de la Rosa G et al. Adv Exp Med Biol 2007: 601: 185-194.
19. Frohm M, Agerberth B, Ahangari G et al. J Biol Chem 1997: 272: 15258-15263.
20. Gudmundsson G H, Agerberth B, Odeberg J et al. Eur J Biochem 1996: 238: 325-332.
21. Larrick J W, Lee J, Ma S et al. FEBS Lett 1996: 398: 74-80.
22. Zaiou M, Gallo R L. J Mol Med 2002: 80: 549-561.
23. Murakami M, Lopez-Garcia B, Braff M et al. J Immunol 2004: 172: 3070-3077.
24. Braff M H, Di Nardo A, Gallo R L. J Invest Dermatol 2005: 124: 394-400.
25. Wu H, Zhang G, Minton J E et al. Infect Immun 2000: 68: 5552-5558.
26. Dorschner R A, Pestonjamasp V K, Tamakuwala S et al. J Invest Dermatol 2001: 117: 91-97.
27. Hase K, Eckmann L, Leopard J D et al. Infect Immun 2002: 70: 953-963.
28. Dombrowski Y, Peric M, Koglin S et al. Arch Dermatol Res: 2010: 302: 401-408.
29. Schauber J, Iffland K, Frisch S et al. Mol Immunol 2004: 41: 847-854.
30. Schauber J, Oda Y, Buchau A S et al. J Invest Dermatol 2008: 128: 816-824.
31. Lehmann B. Exp Dermatol 2009: 18: 97-108.
32. Prosser D E, Jones G. Trends Biochem Sci 2004: 29: 664-673.
33. Bikle D D, Pillai S, Gee E et al. Endocrinology 1989: 124: 655-660.
34. Peric M, Lehmann B, Vashina G et al. J Allergy Clin Immunol: 2010: 125: 746-749.
35. Liu P T, Stenger S, Li H et al. Science 2006: 311: 1770-1773.
36. Braff M H, Gallo R LCurr Top Microbiol Immunol 2006: 306: 91-110.
37. Lopez-Garcia B, Lee P H, Yamasaki K et al. J Invest Dermatol 2005: 125: 108-115.
38. Pinheiro da Silva F, Nizet V. Apoptosis 2009: 14: 509-521.
39. De Y, Chen Q, Schmidt A P et al. J Exp Med 2000: 192: 1069-1074.
40. Tomasinsig L, Pizzirani C, Skerlavaj B et al. J Biol Chem 2008: 283: 30471-30481.
41. Koczulla R, von Degenfeld G, Kupatt C et al. J Clin Invest 2003: 111: 1665-1672.
42. Niyonsaba F, Ushio H, Nagaoka I et al. J Immunol 2005: 175: 1776-1784.
43. Yu J, Mookherjee N, Wee K et al. J Immunol 2007: 179: 7684-7691.
44. Braff M H, Hawkins M A, Di Nardo A et al. J Immunol 2005: 174: 4271-4278.
45. Lowes M A, Bowcock A M, Krueger J G. Nature 2007: 445: 866-873.
46. Bowcock A M, Barker J N. J Am Acad Dermatol 2003: 49: S51-S56.
47. Nickoloff B J, Nestle F O. J Clin Invest 2004: 113: 1664-1675.
48. Tonel G, Conrad C. Int J Biochem Cell Biol 2009: 41: 963-968.
49. Bowcock A M, Krueger J G. Nat Rev Immunol 2005: 5: 699-711.
50. Lande R, Gregorio J, Facchinetti V et al. Nature 2007: 449: 564-569.
51. Kubo T, Fujii M. Nucleosides Nucleotides Nucleic Acids 2001: 20: 1313-1316.
52. Gilliet M, Lande R. Curr Opin Immunol 2008: 20: 401-407.
53. Ganguly D, Chamilos G, Lande R et al. J Exp Med 2009: 206: 1983-1994.
54. Peric M, Koglin S, Dombrowski Y et al. PLoS ONE 2009: 4: e6340.
55. Heilborn J D, Weber G, Gronberg A et al. Exp Dermatol 2010: 19 (4): 332-338.
56. Vahavihu K, Ala-Houhala M, Peric M et al. Br J Dermatol 2010: 163: 321-328.
57. Dombrowski Y, Peric M, Koglin S et al. Sci Transl Med 2011: 3: 82ra38.
58. Nestle F O, Kaplan D H, Barker J. N Engl J Med 2009: 361: 496-509.
59. Viguier M, Guigue P, Pages C et al. Ann Intern Med 2010: 153: 66-67.
60. Sutton C E, Lalor S J, Sweeney C M et al. Immunity 2009: 31: 331-341.
61. Guo L, Wei G, Zhu J et al. Proc Natl Acad Sci U S A 2009: 106: 13463-13468.
62. Renne J, Schafer V, Werfel T et al. Br J Dermatol 2010: 162: 1198-1205.
63. Mills K H, Dunne A. Nat Med 2009: 15: 1363-1364.
64. Stutz A, Golenbock D T, Latz E. J Clin Invest 2009: 119: 3502-3511.
65. Iversen L, Johansen C. Expert Rev Mol Diagn 2008: 8: 697-705.
66. Johansen C, Moeller K, Kragballe K et al. J Invest Dermatol 2007: 127: 2857-2864.
67. Burckstummer T, Baumann C, Bluml S et al. Nat Immunol 2009: 10: 266-272.
68. Fernandes-Alnemri T, Yu J W, Datta P et al. Nature 2009: 458: 509-513.
69. Hornung V, Ablasser A, Charrel-Dennis M et al. Nature 2009: 458: 514-518.
70. Sandgren S, Wittrup A, Cheng F et al. J Biol Chem 2004: 279: 17951-17956.